Streetbeat News

Regulatory

PLG

Platinum Group Metals Ltd. has filed a final base shelf prospectus and a corresponding registration statement with Canadian and US regulatory authorities, allowing for future securities offerings.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

VXRT

Vaxart has provided a business update and reported its Q3 2024 financial results. The company expects to complete enrollment for its COVID-19 Phase 2b study in November 2024. Vaxart is in a solid financial position to achieve regulatory and clinical milestones.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

KSCP

VZ

Verizon has partnered with Knightscope to enhance connectivity for Knightscope's advanced public safety technology. Knightscope's K5 GOV Autonomous Security Robot has received FedRAMP Approval to serve the U.S. Department of Veterans Affairs.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

META

A judge has ruled that the FTC's antitrust lawsuit against Meta can proceed to trial, denying Meta's motion to dismiss the case.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

ALT

Altimmune's drug Pemvidutide is undergoing a phase 2b study for MASH treatment, with results expected in Q2 2025. The MASH market is projected to reach $7.64 billion by 2031. A successful FDA meeting for Pemvidutide in obesity treatment will lead to four phase 3 trials next year.

Portfolio Pulse from

November 13, 2024 | 9:00 pm

AMZN

The US labor board has ruled against Amazon, stating that the company made unlawful promises and threats during mandatory anti-union meetings at a New York City warehouse. The board has banned employers from holding such meetings in the future.

Portfolio Pulse from

November 13, 2024 | 9:00 pm

TSLA

Donald Trump's potential return to the White House is generating optimism on Wall Street due to his business-friendly policies, which could boost economic growth and reduce regulations affecting corporate profits. This could impact companies like Tesla and other electric vehicle makers.

Portfolio Pulse from

November 13, 2024 | 9:00 pm

NGNE

Levi & Korsinsky has initiated an investigation into Neurogene Inc. (NASDAQ:NGNE) for potential securities fraud. This follows Neurogene's recent press release on interim clinical data from its NGN-401 gene therapy trial for Rett syndrome.

Portfolio Pulse from

November 13, 2024 | 8:45 pm

INTC

Intel's stock is rising due to potential positive impacts from the incoming Trump administration on the CHIPS Act funding, which is crucial for the company.

Portfolio Pulse from

November 13, 2024 | 8:45 pm

POWW

AMMO, Inc. is facing a class action lawsuit for alleged violations of securities regulations. The Schall Law Firm is inviting investors who incurred losses to join the lawsuit. The case involves alleged violations of the Securities Exchange Act of 1934.

Portfolio Pulse from

November 13, 2024 | 8:45 pm